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Abstract
Natural killer (NK) cells are well recognized as playing a key role in innate immune defence through cytokine
production and cytotoxic activity; additionally recent studies have identified several novel NK cell functions. The
ability to study NK cells in the sheep has been restricted due to a lack of specific reagents. We report the
generation of a monoclonal antibody specific for ovine NKp46, a receptor which in a number of mammals is
expressed exclusively in NK cells. Ovine NKp46
+ cells represent a population that is distinct from CD4
+ and gδ
+
T-cells, B-cells and cells of the monocytic lineage. The NKp46
+ cells are heterogenous with respect to expression of
CD2 and CD8 and most, but not all, express CD16 - characteristics consistent with NK cell populations in other
species. We demonstrate that in addition to populations in peripheral blood and secondary lymphoid organs,
ovine NKp46
+ populations are also situated at the mucosal surfaces of the lung, gastro-intestinal tract and
non-gravid uterus. Furthermore, we show that purified ovine NKp46
+ populations cultured in IL-2 and IL-15 have
cytotoxic activity that could be enhanced by ligation of NKp46 in re-directed lysis assays. Therefore we conclude
that ovine NKp46
+ cells represent a population that by phenotype, tissue distribution and function correspond to
NK cells and that NKp46 is an activating receptor in sheep as in other species.
Introduction
Natural killer (NK) cells are lymphocytes of the innate
immune system which through production of cytokines
and cytotoxic activity are capable of offering an immediate
response to pathogen-infected and transformed host cells
[1]. NK cells recognise potential targets through a diverse
repertoire of germ-line encoded activating and inhibitory
receptors including members of the killer cell Ig-like
receptor (KIR), Ly49, and CD94:NKG2 families and the
natural cytotoxicity receptors (NCRs) NKp46, NKp30 and
NKp44. Induction of NK cell function is dependent on the
relative balance of signals received from activating and
inhibitory receptors engaged upon interaction with target
cells. Through interactions with other cells of the immune
system, NK cells have also been found to regulate the
development of both innate and adaptive immune
responses in a variety of ways. This includes the activa-
tion/maturation of antigen-presenting cells [2], providing
IFNg for the priming of TH1C D 4
+ T-cells [3], modulating
the function of Treg cells [4] and exerting an immunoregu-
latory effect via the production of IL-10 [5].
Studies in a range of mammalian species have con-
firmed that NKp46 expression is restricted to NK cells
a n dt h a ti ts e r v e sa st h em o s tr e l i a b l eN Kc e l lm a r k e r
available [6-9]. NKp46 is a type I transmembrane glyco-
protein with 2 extracellular C2-type Ig-like domains that
associate via an arginine residue in the transmembrane
region with the ITAM bearing molecules CD3ζ and
FcεRIg [6,9,10]. In humans, NKp46 has been shown to
be a principal activating receptor against a variety of NK
cell targets [10,11]. However, with the exceptions of the
haemagglutinin of influenza virus and the haemaggluti-
nin-neuraminidase of parainfluenza virus and Newcastle
disease virus the ligands for NKp46 are currently
unknown [12,13].
The generation of a bovine NKp46-specific antibody
has facilitated the study of NK cells in cattle and shown
that they contribute to the response against a variety of
pathogens including Mycobacterium bovis, Babesia bovis
and Neospora caninum [14-16]. At present there is no
equivalent antibody in sheep and most previous work
has been restricted to the description of NK-like
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lations [17-20], although a recent publication has
demonstrated that circulating CD16
+/CD14
- cells in
ovine PBMC have the morphological and functional
characteristics of NK cells [21]. In this paper we
describe the generation of a monoclonal antibody speci-
fic for ovine NKp46 and show that cells expressing
N K p 4 6h a v eap h e n o t y p e ,t i s s u ed i s t r i b u t i o na n dc y t o -
toxic function characteristic of NK cells.
Materials and methods
Animals and tissue preparations
Samples were taken from sheep of various breeds aged
between 3 months and 1 year. PBMC were isolated from
blood collected in EDTA by density gradient centrifuga-
tion (900 × g, 30 min) over Ficoll-Paque Plus (Amersham
Biosciences, Little Chalfont, UK) and washed three times
in PBS/2 mM EDTA. Single-cell suspensions from
spleens and lymph nodes were obtained by passing the
products of dilacerated tissues through a mesh with a
50 μM pore size (BD, San Jose, CA, USA). Tissue samples
for immunohistochemical analysis were snap frozen in
isopentane/dry ice and mounted in optimal cutting tem-
perature (OCT) compound (Tissue-Tek, Sakura-Finitek,
Zoeterwoude, The Netherlands). For samples from the
lung, isolated lobes were inflated with a mixture com-
posed of 30% sucrose in water (w/v) and OCT at a ratio
of 2:1 prior to snap freezing. Tissue sections cut to 7 μm
thickness were mounted on poly-L-lysine coated slides
and stored at -80°C until use.
Cloning of the ovine NKp46 gene
The NCBI Ovis aries trace archives [22] were searched
in May 2007 for sequences orthologous to bovine/
human NKp46 (GenBank AF422181/NM_004829) using
the BLASTn algorithm.
Total RNA was extracted from ovine PBMC using
Tri-reagent (Sigma-Aldrich, Poole, Dorset, UK) and
cDNA subsequently synthesized using the Reverse Tran-
scription System (Promega, Madison, WI, USA) with
priming by the Oligo (dT)15 primer, according to the
manufacturer’s instructions. Based on sequence data
obtained from the NCBI bovine WGS archive database
primers in the 5’ (tcactcaccacatcctgagc) and 3’
(cttcctccatgggttccac) UTR of the bovine NKp46 gene
were designed and used in PCR reactions composed of
2.5 μL cDNA, 25 pmol of each primer, 2.5 units of Bio-
taq (Bioline, London, UK), 5 μL SM-0005 10× buffer
(ABgene, Epsom, Surrey, UK) and water to give a final
volume of 50 μL. The cycling conditions for these reac-
tions were 3 min at 95°C, 35 cycles of 1 min at 94°C,
1 min at 55°C, 1 min at 72°C and a final extension period
of 10 min at 72°C. PCR products were purified and sub-
cloned using the pGEM-T Easy vector system (Promega,
Madison, WI, USA) according to the manufacturer’s
instructions and representatives sequenced (DBS Geno-
mics, University of Durham, UK).
DNA and predicted protein sequence analysis was per-
formed using DNAsis Max vr2.7 software (Miraibio,
Alameda, CA, USA) and the tools accessed through the
InterProScan [23] and Scratch Protein Predictor [24]
websites.
Generation of an anti-ovine NKp46 mAb
The extracellular region of the ovNKp46 gene was ampli-
fied from ovine PBMC by PCR using 5’ (aagcttttaccaggca-
gaatctgag) and 3’ (ggatccccagaggaaatggtcttt) primers that
incorporate HindIII and BamHI restriction sites respec-
tively in reactions composed of 2.5 μL cDNA, 25 pmol of
each primer, 2.5 units of Biotaq, 5 μL SM-0005 10× buf-
f e ra n dw a t e rt og i v eaf i n a lv o l u m eo f5 0μLa n dr u n
under the following conditions: 3 min at 95°C, 32 cycles
of 1 min at 94°C, 1 min at 58°C, 1 min at 72°C and a final
extension period of 5 min at 72°C. The product was puri-
fied, cloned into pGEM-T Easy, released by HindIII/
BamHI digestion and then inserted into a mammalian
expression vector containing the hinge, CH2 and CH3
regions of the murine IgG2b gene (kindly provided by
HC Aasheim, The Norwegian Radium Hospital, Oslo,
Norway) as previously described [7,25]. Briefly, 40 μgo f
construct was mixed with 160 μL of Lipofectamine LTX
(Invitrogen, Paisley, UK) and used to transiently transfect
293T cells at ~80% confluence in 162 cm
2 flasks, cells
w e r et h e ng r o w ni ns e r u m - f r e eA I M - Vm e d i a( I n v i t r o -
gen) for four days. The secreted ovNKp46-mFcg2b fusion
protein was then purified on a protein G column (Amer-
sham Biosciences) according to the manufacturer’s
instructions, quantified using a BCA assay (Thermo
Scientific, Rockford, IL, USA) and assayed by both
sodium dodecyl sulphate-polyacrylamide gel electrophor-
esis (SDS-PAGE) and MALDI-TOF (data not shown).
Young, female BALB/c mice were immunized with three
injections: primary and secondary subcutaneous injections
of 100 μga n d2 5μg protein respectively in TitreMax Gold
( T i t r e M a xI n c ,N o r c r o s s ,G A ,U S A ) ,a n daf i n a li n t r a -
peritoneal injection of 25 μg protein in PBS. Spleen cells
were fused with X63 cells by conventional techniques and
hybridoma clones screened by flow cytometry against
P815 cells that had been permanently transfected with a
pFLAG-CMV-3 expression vector (Sigma-Aldrich, Dorset,
UK) containing the complete coding region of ovNKp46
gene. One hybridoma clone was sub-cloned by limiting
dilution and the resulting hybridoma named EC1.1.
Antibodies, flow cytometry, and fluorescent
immunohistochemical analysis
All primary monoclonal antibodies used in this study
were murine, with the exception of SW73.2 which was
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(ovine MHCII: rat IgG2b [27]), both obtained from the
Moredun Research Institute, UK; 44.38 (ovine CD4:
IgG2a [28]), CC126 (bovine CD11b: IgG2b [29]), both
obtained from AbD Serotec, Oxford, UK; δG9 (human
perforin: IgG2b) and 36/E-cadherin (human E-cadherin:
IgG2a) both from BD Biosciences (Erenbodegen, Bel-
gium); VPM13 (ovine IgM: IgG2b - a gift from Bernad-
ette Dutia, Centre for Infectious Diseases, University of
Edinburgh), KD1 (human CD16: IgG2a - a gift from
Daniela Pende, Istituto Nazionale per la Ricerca sul
Cancro, Genova, Italy), CC63 (bovine CD8: IgG2a [30],
CC15 (bovine WC1: IgG2a [31]) and ILA-111 (bovine
CD25: IgG1 [32]). Alexa Fluor 488-conjugated murine
IgG1-specific, PE-conjugated murine IgG2a-, murine
IgG2b- and rat IgG- and Alexa Fluor 647-conjugated
murine IgG2a-specific secondary antibodies were all
obtained from Molecular Probes (Invitrogen). Isotype
controls (all from AbD Serotec) were included in each
experiment.
Two-colour and single colour flow cytometric analysis
was performed using a FACScalibur flow cytometer with
Cellquest software (BD, Franklin Lakes, USA), gated to
include viable cells according to forward and side scatter
parameters. For detection of intra-cellular perforin, cells
were permeabilised using the Cytofix/Cytoperm kit
according to the manufacturer’s instructions (BD
Bioscience). Optimal concentrations of all primary and
secondary antibodies were determined in preliminary
titration assays.
For multi-colour immunofluoresence sections were air
dried prior to fixing in methanol for 10 min at -20°C.
Sections were then washed twice in PBS/0.5% Tween 80
and blocked by incubation in 10% normal goat serum in
PBS/0.5% Tween 80 for 30 min at room temperature.
Slides were then mounted into Sequenza immunostain-
ing units and incubated with primary antibodies at 4°C
overnight. Following two washes in PBS/0.5% Tween 80
slides were incubated with fluorophore conjugated sec-
ondary antibodies for 1 h at room temperature. After a
final wash, slides were mounted in Mowiol mounting
medium (Calbiochem-Novabiochem; San Diego, CA,
USA), and images taken using a SPOT RT3 camera
(Diagnostic Instruments, Sterling Heights, USA)
mounted on an Axiovert 100 inverted microscope (Carl
Zeiss; Welwyn Garden City,U K )a n da n a l y s e du s i n g
SPOT software (Diagnostic Instruments). All antibodies
were diluted in 10% normal goat serum in PBS/0.5%
Tween 80 at the optimal concentrations as determined
in preliminary titration assays.
Cloning and expression of recombinant ovine IL-2
mRNA was extracted from ConA stimulated ovine
PBMC (μMACS kit, Miltenyi Biotec, Bergisch Gladbach,
Germany), followed by complementary DNA synthesis
by SuperScriptIII reverse transcriptase and Oligo(dT)20
primer (both Invitrogen). As information on the
sequence in the 5’ UTR of the ovine IL-2 was not avail-
able, a forward primer designed to recognize 15 nucleo-
tides upstream of the bovine IL-2 start codon to include
the translational initiation region and that also included
the BamHI restriction site was used; 5’-ggatcct-
caactcctgccacaatgta-3’. The reverse primer was 5’-
ctcgagttaagactaacagttacaaaaggt-3’ including XhoI in the
5’ end and recognizing the sequence 89 nucleotides into
the 3’UTR of ovine IL-2. (GenBank NM_001009806.1).
The ovine IL-2 sequence was amplified by PCR using
PfuUltra™(Stratagene, La Jolla, CA, USA) at 3 min at
94°C, 35 cycles of 45 s at 94°C, 30 s at 60°C, 1.5 min at
72°C and a final extension period of 10 min at 72°C.
The obtained PCR product of 608bp was purified,
cloned into 2.1-TOPO vector, released by BamHI/XhoI
digestion and then inserted into pcDNA1 vector (Invi-
trogen). The correctness of the construct was verified by
sequencing. Plasmid DNA was transfected into 293T
cells, ovine IL-2 was harvested in RPMI medium con-
taining 10% FCS and the activity was determined in a
proliferation assay of ConA stimulated ovine PBMC as
described earlier for bovine IL-2 [33]. The supernatant
containing 1 × 10
4U rOvIL-2/mL was stored at -20°C
and used without further purification at the indicated
concentration.
Isolation and culture of NKp46
+ cells
PBMC re-suspended at 5 × 10
7 cells/mL in PBS/0.5%
BSA/2 mM EDTA were incubated with EC1.1 superna-
tant (final dilution of 1:4, based on preliminary titration
analysis) for 30 min at 4°C. After two washes the cells
were incubated with DynaBead pan Mouse IgG (Invitro-
gen) at 4 × 10
6 beads/mL for 30 min at 4°C with shak-
ing. Antibody-labelled cells were magnetically isolated
using a DynaMag-15 (Invitrogen) and washed three
times. Isolated cells were cultured in RPMI1640 supple-
mented with 100 U/mL penicillin, 100 μg/mL strepto-
mycin, 292 μg/mL L-glutamine, 1 mM sodium pyruvate,
50 μM 2-mercaptoethanol, 10% foetal calf serum (all
from Invitrogen), 20 ng/mL recombinant human (rHu)
IL-15 (R&D Systems, Minneapolis, USA) and rOvIL-2 at
200 U/mL. Cultures were incubated at 37°C in 5% CO2
for 7-8 days, with the magnetic beads removed after 48
h and media/cytokine supplemented every 2-3 days as
required. Flow cytometric analysis on day 7-8 demon-
strated that all cultures were > 93% NKp46
+.
Cytotoxicity assays
Cytotoxic activity of cultured ovine NKp46
+ cells was
examined using 4 h
111In-release assays. In brief, YAC-1,
K562 and P815 target cells were re-suspended at 1 ×
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7/mL and 50 μL aliquots were incubated with
111Indium oxine (Amersham Biosciences) at 37°C for 30
min. After six washes in RPMI 1640/5% foetal calf
serum, aliquots of 2.5 × 10
3 labelled target cells were
placed into 96-well V-bottomed plates. In duplicate, two
fold dilutions from 2 × 10
4 to 1.25 × 10
3 of NKp46
+
effector cells (day 7-8 of culture) were added to the
labelled target cells giving effector to target cell ratios of
8:1 to 0.5:1. After incubation at 37°C for 4 h supernatant
was harvested and
111In-release measured in a Wallac
Wizard 1470 Automatic Gamma Counter (PerkinElmer,
Bucks, UK). Percentage specific lysis was calculated as
((sample release-spontaneous release) × 100%/(maximal
release-spontaneous release)) and expressed as the mean
of the duplicated assays. Maximal and spontaneous
release were derived from triplicates of target cells incu-
bated in 0.2% Tween20 and RPMI1640/5% foetal calf
serum, respectively. In re-directed lysis assays P815 cells
were incubated in EC1.1 supernatant or an isotype
matched antibody for 30 min at room temperature
before the final (i.e. sixth) wash removing the
111Indium
oxine label.
Results
The ovine NKp46 gene
Examination of ovine sequence databases by probing with
the bovine and human NKp46 nucleotide sequences only
identified sequences orthologous to human NKp46 exons
4 and 5 (data not shown). To obtain complete sequence of
the ovine NKp46 coding region, cDNA from ovine PBMC
was amplified using PCR primers specific to the 5’ and 3’
UTR of the bovine NKp46 gene and the products cloned.
The consensus sequence (GenBank accession number
HQ433587) of these clones predicts a polypeptide product
that shows 92.5% and 60.9% identity with bovine and
human NKp46 respectively (Figure 1). Following removal
of the predicted signal sequence (1-21aa), the mature poly-
peptide of 285 amino acids contains two extra-cellular Ig-
like domains (25-199aa and 120-212aa), an extra-cellular
stem (213-254aa), a transmembrane region (255-273aa,
which includes a conserved arginine) and a cytoplasmic
tail (274-285aa). The predicted molecular mass of the
mature unglycosylated protein is 32.2kDa, similar to that
of the bovine and human orthologues [7,10]. However,
predicted N-glycosylation sites at Thr139 and Thr249 sug-
gests that the molecular mass of the native protein is likely
to be higher.
Generation of an ovine NKp46-specific monoclonal
antibody
Mice were immunised with a fusion protein composed of
the extra-cellular region of ovine NKp46 and the hinge
and Fc region of murine IgG2b. Screening of hybridomas
derived from these mice for reactivity against P815 cells
transfected with an ovine NKp46-FLAG construct identi-
fied several positive hybridomas. A cloned derivative of
one of these hybridomas, termed EC1.1, was obtained
and found to produce an IgG1 isotype antibody that spe-
cifically recognised ovine NKp46 (Figure 2).
The phenotype of ovine NKp46
+ cells
Flow cytometry analysis of samples from six animals
showed that NKp46 was expressed on between 3-16% of
PBMC. Using 2-colour flow cytometry these cells were
f o u n dt oh a v eaC D 4
-,W C 1
-,I g M
-,M H C I I
- phenotype
indicating that NKp46 is expressed on a cell subset that
is distinct from CD4 T-cells, gδ T-cells, B cells and cells
of the monocytic lineage (Figure 3a). CD2 expression
defined two distinct NKp46
+ subsets - a minor (15-26%)
CD2
hi subset and a larger (74-85%) CD2
lo/- population.
Similarly, CD8 expression defined a CD8
lo/- subset (40-
55%) and a CD8
hi subset (45-60%). The majority (75-
88%) of the NKp46
+ cells were positively stained by the
monoclonal antibody KD1 which is specific for human
CD16 and has been found to cross-react with the bovine
orthologue of this gene and identifies populations within
ovine PBMC [21,34]. Intra-cellular staining identified
the presence of perforin, a protein present in cytotoxic
granules of NK cells and reflecting their cytotoxic
potential, in the majority of NKp46
+ cells (Figure 3b). In
contrast to human and murine NK cells, the ovine
NKp46
+ population did not express CD11b (Figure 3a).
Isolation and in vitro culture of ovine NKp46
+ cells
Using EC1.1 and immunomagnetic separation NKp46
+
cells from PBMC were isolated and then cultured in vitro
in media containing rOvIL-2 and rHuIL-15 to derive pur-
ified NKp46
+ populations. Phenotypic analysis revealed
that the cultured NKp46
+ cells were uniformly CD8
+ and
CD16
lo/-, whilst expression of CD2 defined two distinct
subsets - a major CD2
lo/- population (77-85%) and a
minor CD2
hi population (15-23%) (Figure 4). CD25 was
expressed on > 60% of the cells indicating that the major-
ity of the cells in the cultured populations were activated.
In vitro cultured ovine NKp46
+ cells exhibit cytotoxic
activity
The cytotoxic activity of NKp46
+ cultures from five ani-
mals were examined in standard 4 h In
111-release assays
( F i g u r e5 ) .T h el e v e l so fc y t o t o x i c i t ya g a i n s tY A C - 1a n d
K562 were generally low but exhibit some inter-animal
variation, with cytotoxicity at an effector to target ratio of
8:1 ranging from ~3-22% between individuals. Lysis of
murine FcgR-expressing P815 cells was also low (ranging
from 6-14% at an effector to target ratio of 8:1). However,
for all five cultures pre-incubation of the P815 target cells
with the EC1.1 antibody induced greatly enhanced levels
of cytotoxic activity (ranging from 62-81% at an effector
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not seen when pre-incubated with an isotype controlled
antibody. These re-directed lysis assay results demon-
strate that that all of the NKp46
+ cultures had cytotoxic
capability and that the NKp46 receptor functions as a
cytotoxicity activating receptor in ovine NK cells.
Ovine NKp46
+ cell distribution in lymph nodes and
mucosal surfaces
In other species NK cells have a wide distribution, parti-
cularly in secondary lymphoid tissue and sites of
potential pathogen entry. Using EC1.1 we examined the
distribution of ovine NKp46
+ cells in mucosal and non-
mucosal lymph nodes and in the lungs, gastro-intestinal
tract and non-gravid uterus of sheep.
Immunohistochemical analysis demonstrated that the
distribution of NKp46
+ cells in mucosal and non-mucosal
lymph nodes was similar; NKp46
+ cells were located in
both the para-cortical and medullary areas but only rarely
identified within the follicles (Figure 6a and 6b). Examina-
tion of the gastro-intestinal tract (GIT) revealed that
NKp46
+ cells were absent from the rumen (data not
              1          11         21         31         41         51          
              .          .          .          .          .          .           
Ovine  NKp46  MPSTLAVLLV LGLGLSQRSS TQKQMLSKPA IWVKPSFMIP KGRPATIGCR GAGGAMEYQL 
Bovine NKp46  .......F.. .......... .......... ...R...... ...S...... ...E...... 
Human  NKp46  .S...PA..C V..C....I. A.Q.T.P..F ..AE.H..V. .EKQV..C.Q .NY..V.... 
              61         71         81         91         101        111         
              .          .          .          .          .          .           
Ovine  NKp46  HFEGGLSALE RPKSRPVMNW VKFPIPAMTS HTAGQYRCSY RSGELWSELS DPLELVVTGL 
Bovine NKp46  .........K ....S..... .......... .......... .......... .......... 
Human  NKp46  ....S.F.VD ...PPERI.K ...Y..D.N. RM....S.I. .V......P. NL.D....EM 
              121        131        141        151        161        171 
              .          .          .          .          .          .           
Ovine  NKp46  YDTPTLSVEP RSEVTSGENV TFRCQLATAT STFFLLKAGQ SSRPQLRYGN LWAEFHLGPV 
Bovine NKp46  .......... .......... ..H....... .......K.R .......... .R........ 
Human  NKp46  ........H. GP..I...K. ..Y.R.D... .M.L...E.R ..HV.RG..K VQ...P.... 
              181        191        201        211        221        231         
              .          .          .          .          .          .           
Ovine  NKp46  TPAHRGTYRC FGSYNNHAWS FPSKPVKLLV K--GDAGDTT FAPTEHT-AS DYWDSYELTT 
Bovine NKp46  ....G..... .......... .......... .VP....... .......-S. .......... 
Human  NKp46  .T........ .......... ...E...... T--..IEN.S L..EDP.FPA .T.GT.L... 
              241        251        261        271        281        291         
              .          .          .          .          .          .           
Ovine  NKp46  GTQSQKDHFL WNHTVQNLIR LGLAVLVLVA LMGLLLEDWL HRRKSGKRAH WVSRRRCRRR 
Bovine NKp46  ........L. ...MI..... .......... ...F...... .....QE... RA...G.... 
Human  NKp46  E.GL....A. .D..A...L. M...F..... .VWF.V.... S.KRTRE..S RA.TWEG... 
              301 
              .                      
Ovine  NKp46  LRAQRALET* 
Bovine NKp46  ..........
Human  NKp46  .NT.-T.*-- 
Signal sequence 
Ig-like domain 2 
Transmembrane
     Stem 
Cytoplasmic
Ig-like domain 1 
Figure 1 Alignment of the amino acid sequences of ovine, bovine and human NKp46. Identity of residues between sequences is indicated
with a dot and gaps by a dash. The location of the signal sequence, two extracellular Ig-like domains, stalk, transmembrane region and intra-
cytoplasmic region have been annotated. The sites of potential N-linked glycosylation are in bold, underlined script and the conserved arginine
residue in the transmembrane region is boxed.
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lamina propria of the abomasum, duodenum, jejunum,
ileum and colon, with occasional NKp46
+ cells having an
intra-epithelial location (e.g. Figure 6c and 6f). Addition-
ally it was notable that NKp46
+ cells were scarce in B-cell
aggregates or follicles present in the various compartments
of the gut but were present in high densities in the inter-
follicular areas (e.g. Figure 6d and 6e). NKp46
+ cells were
also evident in sub-epithelial locations in the uterus (Fig-
ure 6g) and in the lung were found in the sub-epithelium
of airways and also within the interstitium (Figure 6h).
NKp46
+ cells in the pre-scapular and mesenteric
lymph nodes constituted 2.6-6.2% and 2.2-4.2% of the
mononuclear cell population respectively, and were also
found at a similar frequency in the spleen (3.2-4.9%).
The phenotype of these populations were generally con-
sistent with that of the NKp46
+ cells in PBMC but
tended to demonstrate a more homogenous CD2
lo and
CD8
lo expression (Figure 3c).
Discussion
Research into ovine NK cells has been impeded by a
lack of specific reagents. Indeed, until recent work by
Elhmouzi-Younes et al. [21], identifying the CD16
+/CD14
-
subset of ovine PBMC as NK cells, studies in sheep had
been confined to the description of NK-like function in
unfractionated lymphocyte populations from blood and
uterine tissue [17-20]. In this study we report the genera-
tion of a monoclonal antibody specific for ovine NKp46, a
cell surface marker specifically expressed by NK cells in a
variety of species including humans, primates, mice, rat
and cattle and that has been proposed as the most
definitive marker for NK cells in mammals [6-9,35]. We
have demonstrated that the phenotype, distribution and
function of the ovine NKp46
+ cells identified with this
antibody correspond with those previously described for
NK cells in other species.
NK cells form a phenotypically heterogenous popula-
tion, with subsets of distinct phenotypes frequently asso-
ciated with particular functions and/or anatomical
location [36]. Comprehensive inter-species comparisons
of NK cell phenotype is precluded by differences in NK
cell markers expressed in individual species [35]. How-
ever the phenotype of ovine NKp46
+ cells in PBMC and
secondary lymphoid tissues (spleen, mucosal and non-
mucosal lymph nodes) was consistent with that of NK
cells in other species in several respects. Firstly, NKp46
+
cells formed subsets that were distinct from CD4
+
T-cell, gδ
+T-cell, B-cell and monocytic populations [7,9].
Secondly, approximately 80-90% of the NKp46
+ cells
expressed CD16 (FcgRIII) - the receptor that mediates
antibody-dependent cell-mediated cytotoxicity by NK
cells - comparable to levels observed in the equivalent
populations in cattle and in human PBMC [34,36].
These data indicate that the CD16
+/CD14
- phenotype
used recently by Elhmouzi-Younes et al. [21] to define
peripheral ovine NK cells successfully identifies most
but not all NKp46
+ cells and could be equally well
applied to NK cells in secondary lymphoid tissues.
Thirdly, ovine NKp46
+ cells expressed perforin, an inte-
gral part of the granule exocytosis mediated cytotoxicity
machinery used by NK cells for target cell lysis. The
constitutive expression of molecules involved in this
cytotoxicity pathway is characteristic of NK cells with
lytic function and permits them to function without the
requirement for induced expression that is seen in CD8
+
T-cells [37,38]. Fourthly, as seen in humans and cattle
NK cells, ovine NKp46
+ cells exhibited varied levels of
C D 2a n dC D 8e x p r e s s i o n ,s u c ht h a ti nb l o o dC D 2
-/lo
and CD2
hi as well as CD8
-/lo and CD8
hi subsets could be
distinguished, whilst in secondary lymphoid tissues a
more homogenous CD2
lo/CD8
lo population was observed
[7,39]. Of note, ovine NKp46
+ cells did not express
CD11b, a molecule expressed on both human and mur-
ine NK cells; a previous report has described bovine NK
cells as also having a CD11b
- phenotype, suggesting this
may be a general characteristic of ruminant NK cells [40].
In this study we have demonstrated that ovine NKp46
+
cells isolated from PBMC and cultured in the presence of
rOvIL-2/rHuIL-15 exhibited cytotoxicity, one of the
“classic” NK cell functions. In direct lysis assays against
the xenogenic target cell lines K562 and YAC-1 the levels
of cytotoxicity achieved by NKp46
+ cells varied between
individual sheep, similar to observations made in cattle
[7]. However, in redirected lysis assays using the anti-
NKp46 antibody, NKp46
+ cells from all individuals
C
o
u
n
t
s
FL 1
Figure 2 EC1.1 is specific for ovine NKp46. P815 cells transfected
with an ovNKp46-FLAG construct are stained similarly by supernatant
from EC1.1 (blue line) and a FLAG-specific antibody (red line) but not
by an isotype control antibody (black line). Untransfected P815 cells
are not stained by EC1.1 supernatant (solid grey).
Connelley et al. Veterinary Research 2011, 42:37
http://www.veterinaryresearch.org/content/42/1/37
Page 6 of 12Figure 3 Analysis of the phenotype of ovine NKp46
+ populations. (A)Two-colour flow cytometry analysis of ovine PBMC co-stained with
EC1.1 and a selection of monoclonal antibodies against CD2, CD4, CD8, CD11b, CD16, WC1, IgM and MHCII. WC1 and IgM are surface molecules
expressed by subsets of gδ T-cells and B-cells respectively. (B) Perforin expression by NKp46
+ PBMC. Cells expressing NKp46 were stained with
anti-perforin monoclonal antibody (solid line) or an isotype control (broken line). (C) Two-colour flow cytometry analysis of mesenteric and pre-
scapular lymph nodes and the spleen cell populations co-stained with EC1.1 and monoclonal antibodies against CD2 and CD8. The results
shown are representative of the results obtained from a minimum of five animals.
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Page 7 of 12showed high levels of killing, demonstrating that i) all of
the ovine NKp46
+ cultures had the capacity to mediate
cytotoxicity, with differences of cytotoxicity observed in
direct lysis assays therefore likely to represent variation
in the repertoire of expressed inhibitory/activatory recep-
tors by NKp46
+ cells from individual sheep and ii) as
reported in other species engagement of the NKp46
receptor is a potent trigger for NK cell activity [6,7,9].
During culture, NKp46
+ cells were non-adherent and
became enlarged with prominent lamellopodia (data not
shown). These morphological characteristics and the pre-
dominantly CD2
lo/CD8
hi/CD25
+ phenotype, resembled
those described for ovine CD16
+/CD14
- cells and bovine
NKp46
+ cells [21] and provide further evidence that
ovine NKp46
+ and CD16
+/CD14
- cells represent overlap-
ping populations. Interestingly we noted that cultured
NKp46
+ cells were CD16
lo, suggesting downregulation of
CD16 during activation, in contrast to the upregulation
seen in cattle [34]. This downregulation may contribute
to the low level of cytotoxicity reported by Elhmouzi-
Younes et al. [21] in re-directed cytotoxicity assays using
the anti-CD16 antibody, although data from similar stu-
dies in cattle suggest that NKp46 engagement induces
higher cytotoxicity than that of CD16 [34].
NK cells are widely distributed throughout both lym-
phoid and non-lymphoid tissues [41]. Consistent with this,
we identified ovine NKp46
+ populations in blood, lymph
nodes, spleen and at the mucosal surfaces of the lung, gas-
tro-intestinal tract (GIT) and uterus. Within lymph nodes
ovine NKp46
+ cell distribution corresponded with that
described for NK cells in bovine, murine and human
lymph nodes - with scattered cells present in the paracor-
tical and medullary regions but largely absent from the fol-
licles [3,8,34,42]. A principal role of lymph node NK cells
is to regulate adaptive and innate immunity through parti-
cipating in a reciprocal activation dialogue with dendritic
cells and via the provision of IFNg for TH1p r i m i n go f
CD4
+ T-cells [3,43,44]. Paracortical NK cells are in close
proximity to DC and T-cells and optimally situated for
this function. In contrast it is thought that medullary NK
cells represent cells exiting the lymph nodes and are there-
fore of limited functional relevance [43]. The distribution
of NK cells at the mucosal surfaces has not been described
previously in ruminants. NKp46
+ cells were found in the
mucosa of all compartments of the ovine GIT examined
but were not detected in the rumen. Absence of NKp46
+
cells in the rumen probably reflects the distinct physiologi-
cal role of the ruminant fore-stomachs (rumen, omasum
and reticulum) which have a stratified epithelial lining and
act as a fermentation system. In the rest of the ovine GIT
NKp46
+ cells were present at high density adjacent to lym-
phoid aggregates (such as Peyer’s patches) and found at a
lower density throughout the lamina propria with occa-
sional cells present in an intra-epithelial position. This dis-
tribution is similar to that described in mice and humans
[45,46] and reflects a functional role of NK cells in inter-
acting with antigen-presenting cells, which are also found
predominantly in the lamina propria. NKp46
+ cells were
also found in sub-epithelial locations in the non-gravid
uterus and in both sub-epithelial locations and within the
parenchyma of the lungs. Mucosal surfaces, especially
those of the gut and lung, are major portals for pathogen
entry. NK cells in the lung have been shown to contribute
to protection against a wide range of pulmonary pathogens
by production of IFNg and/or cytotoxic activity [47]. In
contrast, recent evidence from human and murine studies
suggest that the majority of NK cell in the GIT lack IFNg
and cytotoxic function but contribute to mucosal immu-
nity against pathogens by production of IL-22 [45,46].
Although uterine NK cells are also considered to have an
anti-pathogenic function, evidence for this is limited [48],
with most uterine NK cell studies focusing on their func-
tional role in regulating placental development during
pregnancy [49]. However, uterine NK cell biology is com-
plex and the exact role(s) of uterine NK cells remains con-
troversial [48,49]. Futhermore, the significant differences
between the reproductive biology of ruminants (cotyledon-
ary-epitheliochorial placental structure) and rodents/
Figure 4 Phenotype of cultured NKp46
+ populations.O v i n eN K p 4 6
+ populations after 7-8 days of in vitro culture were stained with
monoclonal antibodies against CD2, CD8, CD16 and CD25 (solid lines) or isotype controls (broken lines). Results are shown from one culture
that was representative of those derived from five animals.
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Figure 5 Cultured Ovine NKp46
+ cells exhibited cytotoxic activity. Cytotoxicity of NKp46
+ cultures from five animals as determined in 4 h-
111In release assays. Lysis of the xenogenic NK-sensitive cells lines K562 and YAC1 exhibited inter-animal variation, with lysis ranging from
approximately 3-22% at effector to target ratios of 8:1. Direct lysis of P815 cells (FcgR
+) was low (6-14% at effector to target ratios of 8:1), but in
redirected cytotoxicity assays pre-incubation with anti-NKp46 antibody (EC1.1) dramatically increased cytotoxic activity (62-81% at effector to
target ratios of 8:1) of all NKp46
+ cultures. Pre-incubation with an isotype control antibody did not elevate cytotoxicity above that seen in the
absence of antibody.
Connelley et al. Veterinary Research 2011, 42:37
http://www.veterinaryresearch.org/content/42/1/37
Page 9 of 12G F H
D F E
L
L
F
F
F
B
D D
Fo
P
A B
A C D
L
Figure 6 Distribution of ovine NKp46
+ cells in lymph nodes and mucosal surfaces. Sections from ovine pre-scapular lymph node (A -
cortex and B - medullary zone), abomasum (C), duodenum (D), ileum (E), colon (F), uterus (G) and lung (H). NKp46
+ cells: green; B-cells (IgM
+)
red; CD4
+ T-cells blue in panel A and B; Epithelial cells (E-cadherin
+) blue in parts C-H. White arrows: individual NKp46
+ cells. Red arrows:
putative intra-epithelial NKp46
+ cells. “Fo": follicle and “P": paracortex. “L": lymphocytic aggregate. Isotype matched controls demonstrated diffuse
and dull background fluorescence in both the red and green channels (data not shown), however this could easily be distinguished by character
and/or intensity from the bright cell-surface staining seen with the NKp46 and IgM-specific antibodies. Autofluorescent artifacts such as those
demonstrated by the yellow arrows (e.g. in C and D) were not uncommon in the tissues examined. A scale for each of the figure parts is given.
Images are taken from tissues that were representative of samples taken from a minimum of three animals as determined by preliminary single
colour immuncytochemistry analysis.
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Page 10 of 12primates (discoid-haemochorial placentae) suggest that
functional equivalence of uterine NK cells in these species
can not be totally assumed.
In conclusion, we have provided a preliminary charac-
terisation of ovine NKp46
+ cells and shown them to
have a phenotype, distribution and function similar to
those of NK cells in other species. Recently there have
been rapid advances in understanding of NK cell biol-
ogy, including the identification of novel functions
[5,45,46] and evidence of “memory-like” NK cell subsets
[50,51]. The availability of a monoclonal antibody speci-
fic for ovine NK cells will hopefully facilitate further stu-
dies both of the comparative biology of these cells in
different species and also to investigate their role in
immunity to important production diseases of sheep.
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